2641899-38-7

2641899-38-7 structure
2641899-38-7 structure
  • Name: FD274
  • Chemical Name: FD274
  • CAS Number: 2641899-38-7
  • Molecular Formula: C22H14ClFN6O2S
  • Molecular Weight: 480.90
  • Catalog: Signaling Pathways PI3K/Akt/mTOR mTOR
  • Create Date: 2023-10-20 09:49:54
  • Modify Date: 2024-01-06 13:45:50
  • FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1].

Name FD274
Description FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1].
Related Catalog
Target

PI3Kα:0.65 nM (IC50)

PI3Kβ:1.57 nM (IC50)

PI3Kδ:0.65 nM (IC50)

PI3Kγ:0.42 nM (IC50)

mTOR:2.03 nM (IC50)

References

[1]. Chengbin Yang, et al. Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K/mTOR dual inhibitor for the treatment of acute myeloid leukemia. Eur J Med Chem. 2023 Oct 5;258:115543.  

Molecular Formula C22H14ClFN6O2S
Molecular Weight 480.90
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.